Overview:
Recent advances in biotechnology, cloning and genetics have made possible a
wide range of new technologies and products. Over the next decade these may
revolutionise both commercial livestock production and the companion animal
sector. This Animal Pharm report is the first to identify the commercial
potential of these new technologies.
Key features of the report
An analysis of advances in four key industry sectors:
- transgenic animals, cloning and genomic sequencing
- therapies using bacteriophages, monoclonal antibodies, stem cells and
therapeutic proteins vaccines, including plant-based and DNA vaccines
- diagnostics, including tests for BSE, trace back of food and inherited
diseases
Each of these sections identifies the leading companies and their
technologies; the commercial potential of the developments; and the technical
and commercial constraints that must be overcome
- A review of the structure of the animal biotechnology industry,
identifying the key players and the partnerships that have developed between
the major animal health multinationals and the R&D-focused start-ups
- 67 profiles of the leading academic and government research institutions
and commercial companies at the cutting edge of animal biotechnology
R&D, allowing you to identify potential R&D partners, or your
competitors in developing the technologies of the future
- An easy-to-understand introduction to the technical background to the new
industry and a glossary of key terms, making this report accessible to
specialists and non-specialists alike
- An analysis of the key issues in terms of regulations and public
acceptance, allowing you to judge the commercial potential of new
technologies and products
- More than 150 academic and business references, allowing you to further
investigate the key research that has been identified.
Executive Summary:
This report covers the new opportunities in animal health created by
biotechnology, including transgenic animals and cloning, genome sequencing,
genetic testing, recombinant proteins and vaccines. The science is put in the
context of commercial opportunities for applications of scientific breakthroughs
to develop new products for animal health. In order to understand the
technology and its commercial potential, the history of biotech products for
animal health is reviewed, including background on the drugs and vaccines that
have been approved worldwide. The regulatory issues raised by these new
technologies, and how the regulators are approaching transgenic and cloned
animals and their products is reviewed, with the latest information through the
end of 2003. | 
View Cart
